Kidney Transplant

Global Kidney Transplant Market to Reach US$91.1 Billion by 2030

The global market for Kidney Transplant estimated at US$81.2 Billion in the year 2024, is expected to reach US$91.1 Billion by 2030, growing at a CAGR of 1.9% over the analysis period 2024-2030. Living Donor Transplant, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$58.3 Billion by the end of the analysis period. Growth in the Paired Kidney Transplant segment is estimated at 1.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$22.1 Billion While China is Forecast to Grow at 3.9% CAGR

The Kidney Transplant market in the U.S. is estimated at US$22.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$17.1 Billion by the year 2030 trailing a CAGR of 3.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 1.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.0% CAGR.

Global Kidney Transplant Market – Key Trends & Drivers Summarized

Why Is Kidney Transplantation Gaining Urgency Amid Rising Renal Disease Prevalence?
Kidney transplantation remains the most definitive and cost-effective treatment for end-stage renal disease (ESRD), which is growing rapidly worldwide due to the increasing incidence of diabetes, hypertension, and aging populations. As dialysis-dependent patients continue to rise, the demand for renal replacement therapy is outpacing donor availability, placing kidney transplantation at the center of healthcare planning and investment. Unlike dialysis, transplants improve both survival and quality of life, while significantly reducing long-term treatment costs, hospitalizations, and systemic complications.

In addition to therapeutic efficacy, global awareness campaigns, improvements in donor-recipient matching, and enhancements in surgical precision have collectively elevated transplantation success rates. Increased government funding, organ-sharing alliances, and public-private initiatives are enabling broader access to transplant services in both developed and emerging economies. Simultaneously, educational outreach and community engagement are helping overcome cultural and logistical barriers to organ donation, particularly in underpenetrated regions.

How Are Technological and Clinical Innovations Transforming Kidney Transplantation?
Rapid advancements in transplant immunology and diagnostics are enabling better graft survival and patient outcomes. The introduction of precision HLA-typing, panel-reactive antibody (PRA) monitoring, and next-generation sequencing is improving compatibility analysis and reducing the risk of rejection. Modern immunosuppressive regimens are increasingly patient-tailored, minimizing long-term side effects while enhancing graft longevity. Innovations such as desensitization therapies, paired kidney exchanges, and antibody removal protocols are making transplantation viable for previously incompatible patients.

Additionally, novel technologies such as ex vivo organ perfusion and hypothermic machine preservation are being employed to optimize the quality and viability of donor kidneys. Artificial intelligence and predictive analytics are helping clinicians assess donor-recipient suitability and predict post-transplant outcomes. Robotics and minimally invasive approaches are also improving procedural safety, reducing recovery time, and expanding surgical access for high-risk patients. These clinical and technological advances are ensuring that kidney transplantation remains at the forefront of renal care.

Where Is Demand Rising Most and How Are Systems Expanding to Meet It?
North America and Western Europe remain leaders in kidney transplantation infrastructure, supported by established organ procurement organizations, reimbursement frameworks, and high public awareness. However, Asia-Pacific is witnessing the fastest growth, with expanding ESRD prevalence, growing transplant centers, and significant government investment in public health systems. India and China, in particular, are scaling transplant capacity through improved registries and cross-matching capabilities, despite ongoing ethical and logistical challenges.

Latin America and the Middle East are also building regional networks and investing in transplant logistics and post-operative care. In Africa, while transplantation remains limited to select urban centers, international collaborations are helping train professionals and develop regulatory frameworks. Globally, living donor programs are being promoted alongside deceased donor registries to mitigate the widening demand-supply gap. Public health agencies are now focusing on improving transparency, equity, and traceability in organ allocation systems to ensure ethical and efficient utilization of scarce resources.

The Growth in the Kidney Transplant Market Is Driven by Several Factors…
It is driven by the increasing global burden of ESRD, greater public acceptance of organ donation, and the expansion of national and cross-border transplant networks. Technological innovations in donor-recipient matching, organ preservation, and immunosuppressive drug development are reducing transplant risks and improving long-term outcomes. Rising investments in transplant infrastructure, including digital registries, histocompatibility labs, and logistics systems, are making transplants more accessible across socioeconomic groups.

Growth is also supported by the inclusion of transplantation in government-backed health coverage programs, especially in middle-income countries. The emergence of living donor exchange platforms, advances in surgical robotics, and clinical research into xenotransplantation and artificial organs further underscore the market’s dynamic trajectory. As healthcare systems prioritize quality-of-life outcomes and cost-effective interventions, kidney transplantation continues to grow as a critical component of comprehensive renal care worldwide.

SCOPE OF STUDY:

The report analyzes the Kidney Transplant market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Living Donor Transplant Type, Paired Kidney Transplant Type, Deceased Donor Transplant Type); Age Group (Children, Adults); End-User (Hospitals End-User, Specialty Clinics End-User, Transplant Centers End-User, Other End-Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• AbbVie Inc.
• Astellas Pharma Inc.
• B. Braun Melsungen AG
• BioLife Solutions, Inc.
• Bristol-Myers Squibb Company
• CareDx, Inc.
• CSL Behring
• DaVita Inc.
• eGenesis
• Fresenius Medical Care AG & Co. KGaA
• Grifols, S.A.
• Immucor, Inc.
• Medtronic plc
• Novartis AG
• Organ Recovery Systems, Inc.
• Pfizer Inc.
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
• TransMedics, Inc.
• United Therapeutics Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.